Lee S Cohen

Array ( [id] => 1495501 [patent_doc_number] => 06403587 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1- binding to its CCR 1 receptor' [patent_app_type] => B1 [patent_app_number] => 09/380269 [patent_app_country] => US [patent_app_date] => 2000-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31722 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 4372 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403587.pdf [firstpage_image] =>[orig_patent_app_number] => 09380269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1216920 [patent_doc_number] => 06706745 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-16 [patent_title] => 'Biphenylamidine derivatives' [patent_app_type] => B1 [patent_app_number] => 09/554799 [patent_app_country] => US [patent_app_date] => 2000-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22154 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 748 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/706/06706745.pdf [firstpage_image] =>[orig_patent_app_number] => 09554799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575199 [patent_doc_number] => 06469006 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Antiviral indoleoxoacetyl piperazine derivatives' [patent_app_type] => B1 [patent_app_number] => 09/571460 [patent_app_country] => US [patent_app_date] => 2000-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24462 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/469/06469006.pdf [firstpage_image] =>[orig_patent_app_number] => 09571460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550109 [patent_doc_number] => 06346534 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto' [patent_app_type] => B1 [patent_app_number] => 09/570239 [patent_app_country] => US [patent_app_date] => 2000-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12529 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346534.pdf [firstpage_image] =>[orig_patent_app_number] => 09570239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1485674 [patent_doc_number] => 06365592 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'Phosphonic and carboxylic acid derivatives as inhibitors of protein tyrosine phosphatase-1B (PTP-1B)' [patent_app_type] => B1 [patent_app_number] => 09/570092 [patent_app_country] => US [patent_app_date] => 2000-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11651 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365592.pdf [firstpage_image] =>[orig_patent_app_number] => 09570092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1478627 [patent_doc_number] => 06451796 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Fused pyrazine compounds' [patent_app_type] => B1 [patent_app_number] => 09/554166 [patent_app_country] => US [patent_app_date] => 2000-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40085 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 1035 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451796.pdf [firstpage_image] =>[orig_patent_app_number] => 09554166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1566758 [patent_doc_number] => 06376492 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Compounds and methods for inhibition of HIV and related viruses' [patent_app_type] => B1 [patent_app_number] => 09/567857 [patent_app_country] => US [patent_app_date] => 2000-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27954 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 538 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376492.pdf [firstpage_image] =>[orig_patent_app_number] => 09567857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4380146 [patent_doc_number] => 06303606 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Use of selective antagonists of the .alpha.1B-adrenergic receptor for improvement of sexual dysfunction' [patent_app_type] => 1 [patent_app_number] => 9/565842 [patent_app_country] => US [patent_app_date] => 2000-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12552 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303606.pdf [firstpage_image] =>[orig_patent_app_number] => 565842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1478442 [patent_doc_number] => 06344560 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-05 [patent_title] => 'Nitroaromatic solubilizer for nitroxyls in aromatic solvents' [patent_app_type] => B1 [patent_app_number] => 09/564221 [patent_app_country] => US [patent_app_date] => 2000-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5944 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 338 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/344/06344560.pdf [firstpage_image] =>[orig_patent_app_number] => 09564221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4346463 [patent_doc_number] => 06284766 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => '9H-pyrimido [4,5-b] indole derivatives: CRF1 specific ligands' [patent_app_type] => 1 [patent_app_number] => 9/561569 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8502 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 396 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284766.pdf [firstpage_image] =>[orig_patent_app_number] => 561569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1528316 [patent_doc_number] => 06479470 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Ligands for metabotropic glutamate receptors and inhibitors of NAALAdase' [patent_app_type] => B1 [patent_app_number] => 09/559978 [patent_app_country] => US [patent_app_date] => 2000-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 23747 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479470.pdf [firstpage_image] =>[orig_patent_app_number] => 09559978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 958857 [patent_doc_number] => 06953803 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-10-11 [patent_title] => 'Pyrimidine compounds' [patent_app_type] => utility [patent_app_number] => 10/030661 [patent_app_country] => US [patent_app_date] => 2000-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21243 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/953/06953803.pdf [firstpage_image] =>[orig_patent_app_number] => 10030661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446870 [patent_doc_number] => 06369056 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Cyclic urea and cyclic amide derivatives' [patent_app_type] => B1 [patent_app_number] => 09/552356 [patent_app_country] => US [patent_app_date] => 2000-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10748 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/369/06369056.pdf [firstpage_image] =>[orig_patent_app_number] => 09552356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636423 [patent_doc_number] => 06380235 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Benzimidazolones and analogues' [patent_app_type] => B1 [patent_app_number] => 09/552546 [patent_app_country] => US [patent_app_date] => 2000-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16245 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380235.pdf [firstpage_image] =>[orig_patent_app_number] => 09552546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560220 [patent_doc_number] => 06436929 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Cyclothiocarbamate derivatives as progesterone receptor modulators' [patent_app_type] => B1 [patent_app_number] => 09/552354 [patent_app_country] => US [patent_app_date] => 2000-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27521 [patent_no_of_claims] => 111 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 301 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436929.pdf [firstpage_image] =>[orig_patent_app_number] => 09552354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1490822 [patent_doc_number] => 06417214 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => '3,3-substituted indoline derivatives' [patent_app_type] => B1 [patent_app_number] => 09/552352 [patent_app_country] => US [patent_app_date] => 2000-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9571 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/417/06417214.pdf [firstpage_image] =>[orig_patent_app_number] => 09552352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1490707 [patent_doc_number] => 06417189 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'AZA compounds, pharmaceutical compositions and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/551618 [patent_app_country] => US [patent_app_date] => 2000-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14276 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/417/06417189.pdf [firstpage_image] =>[orig_patent_app_number] => 09551618 [rel_patent_id] =>[rel_patent_doc_number] =>)